![]()
MIRA INFORM
REPORT
|
Report Date : |
24.02.2011 |
IDENTIFICATION DETAILS
|
Name : |
MOLECULAS FINAS DE
MEXICO S.A. DE C.V. |
|
|
|
|
Registered Office : |
Filipinas 110 esquina Necaxa 125, Colonia Portales, Delegación Benito Juárez |
|
|
|
|
Country : |
Mexico |
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Date of Incorporation : |
19.06.1991 |
|
|
|
|
Legal Form : |
Stock Company of Variable Capital |
|
|
|
|
Line of Business : |
Import and |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$100,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
Mexico |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
CORRECT
COMPANY NAME |
:
|
MOLECULAS FINAS DE MEXICO
S.A. DE C.V. |
|
TRADE
NAME |
:
|
N/A" |
|
TAXPAYER
REGISTRATION |
:
|
RFC MFM-910619-2N5 |
|
MAIN
ADDRESS |
:
|
Filipinas 110 esquina Necaxa
125, Colonia Portales, Delegación
Benito Juárez |
|
CITY |
:
|
México DF |
|
DEPARTMENT/STATE |
:
|
Estado de México |
|
COUNTRY |
:
|
MEXICO |
|
TELEPHONE |
:
|
56727755 - 55390432 |
|
FAX |
:
|
55390106 |
|
WEB
SITE |
:
|
COMMENTS
.-
Additional E-mail: info@moleculas-finas.com
INCORPORATION : 1991
SHAREHOLDERS '
EQUITY : Ps$84,808,262.=
Pesos (31.12.2008)
SALES : 177,704,904.00
EMPLOYEES : 55
PAYMENTS : P2 Usually to terms/good
CHIEF EXECUTIVE : FUENTES RAMIREZ,
FILOGONIO
DISPOSITION : TOTAL (Full
information and figures).
|
LEGAL
ESTATUS |
:
|
Stock Company of Variable Capital |
|
DATE
OF INCORPORATION |
:
|
19JUN1991 |
|
START
OF OPERATIONS |
:
|
N/A |
|
REGISTERED
IN |
:
|
Mexico DF |
|
NOTARY
OFFICE |
:
|
N/A |
|
DURATION |
:
|
99 years |
|
REGISTRATION |
:
|
N/A |
|
INITIAL
CAPITAL |
:
|
N/A |
|
CURRENT
PAID-IN CAPITAL |
:
|
N/A |
|
LAST
CAPITAL INCREASE |
:
|
N/A |
|
SHAREHOLDERS'
EQUITY |
:
|
Ps$84,808,262.= Pesos
(31.12.2008) |
|
TYPE
OF SHARES |
:
|
N/A |
|
LISTED
AT STOCK EXCHANGE |
:
|
No |
|
SHARE
VALUE |
:
|
N/A |
|
CURRENT
EXCHANGE RATE |
:
|
Ps$12.= per US$1.= Dollar |
|
MEMBERSHIP |
:
|
N/A |
|
FULL NAMES / COMPANY NAME |
TITLE |
OWNERSHIP % |
|
FUENTES RAMIREZ, FILOGONIO |
General Director |
50% |
|
ESPARZA SAUCEDO, MARIA
GUADALUPE |
Administrative Director |
50% |
|
MANRIQUE RANGEL, TERESA |
Finance Director |
|
FUENTES
RAMIREZ, FILOGONIO
NATIONALITY : Mexican
BORN :
23SEP1958
TAX ID :
FURF5809238V0
PROFESSION :
Engineer
Associated as per our database to :
|
Company |
Position |
Tax. Reg. |
Country |
|
MF GRUPO EMPRESARIAL S.A. DE C.V. |
General Director |
|
MEXICO |
|
BASICOS FEED GRADE S.A. DE
C.V. |
General Director |
BFG-930901-Q81 |
MEXICO |
|
GENERICOS VETERINARIOS S.A.
DE C.V. |
General Director |
GVE-090727-KI6 |
MEXICO |
ESPARZA SAUCEDO, MARIA GUADALUPE
NATIONALITY : Mexican
BORN :
30NOV1957
TAX ID :
EASG571130JS9
BACKGROUND INFORMATION .-
Master's Degree in Sciences
Associated as per our database to :
|
Company |
Position |
Tax. Reg. |
Country |
|
BASICOS FEED GRADE S.A. DE
C.V. |
Director |
BFG-930901-Q81 |
MEXICO |
|
COMPANY NAME |
COUNTRY |
AX. REG. |
RELATION |
|
BASICOS FEED GRADE S.A. DE
C.V. |
MEXICO |
BFG-930901-Q81 |
Related |
|
GENERICOS VETERINARIOS S.A.
DE C.V. |
MEXICO |
GVE-090727-KI6 |
Related |
|
RETOS Y METAS S.A. DE C.V. |
MEXICO |
|
Related |
|
VETI MEDICA S.A. DE C.V. |
MEXICO |
|
Related |
MAIN
ACTIVITY .-
Subject is engaged in import and sale of raw materials for the
pharmaceutical, cosmetic and food industries.
Main products: Acetylsalicylic acid, ampicillin, metronidazole benzoyl,
carbadox, ciprofloxacin, dimetridazole, enrofloxacin, fluconazole, Disodic
fosfomycin, USP23 guafenezine,
ketoconazole, loratadine, nicarbazine, olanquindox, sodium sulfacetamide,
paracetamol, among others.
IMPORT :
Yes
(From
at 120-day terms)
EXPORT : No
|
%
CASH SALES/METHOD |
:
|
N/A |
|
%
CREDIT SALES/TERMS |
:
|
100% (Terms: 30, 60 days) |
|
%
FOREIGN SALES (COUNTRIES) |
:
|
N/A |
|
%
DOMESTIC PURCHASES |
:
|
10% |
|
%
FOREIGN PURCHASES |
:
|
N/A |
|
SELLING
TERRITORY |
:
|
Domestic market |
|
EMPLOYEES |
:
|
55 |
LOCATION
.-
|
Premises |
:
|
Own |
|
Monthly
Amount |
:
|
N/A |
|
Time
Occupied |
:
|
N/A |
|
Area |
:
|
N/A |
|
Floors |
:
|
2 |
Remarks and other Premises .-
Subject is located in a urban area of the city near Metro Portales, between
Av. Cuauhtemoc and Av. Calzada de Tlalpan.
Branch: Av. Ocho de Julio 1382, Colonia Morelos,
Guadalajara/Jalisco. Tel. (52.33) 8108849 (Rented premises)
COMMENTS .-
(*) Subject's personnel belongs to the MF GRUPO EMPRESARIAL S.A. DE C.V.
(related company) payroll.
Its main customers include:
- Internacional Química Carte S.A. de C.V.
- Pecuarios Laboratorios S.A. de C.V.
- Química Agrovet S.A. de C.V.
It has been granted the ISO 9001:2008 Certification (Approved Group of
Western Service Suppliers).
|
Interviewee(s) |
:
|
Alejandra Espinoza |
|
Position(s) |
:
|
Accountant |
|
Cooperation |
:
|
TOTAL (Full information and figures). |
|
Information
Provided |
:
|
She confirmed and updated this company's operating information, as
well as provided the Annual Balance Sheet as of 31/12/2010 (12 months), which
is expressed in Pesos. |
|
BALANCE SHEET DATE |
31DEC2010 |
|
PERIOD |
12
months |
|
CURRENCY |
Pesos |
|
ASSETS |
|
|
CASH/BANKS |
5,280,134.00 |
|
RECEIVABLES |
67,878,297.00 |
|
INVENTORY |
38,294,670.00 |
|
OTHERS |
16,827,269.00 |
|
TOTAL CURRENT |
128,280,370.00 |
|
FIXED |
7,642,037.00 |
|
TOTAL ASSETS |
135,922,407.00 |
|
LIABILITIES |
|
|
TOTAL CURRENT |
53,772,694.00 |
|
SHAREHOLDERS' EQUITY |
|
|
TOTAL
EQUITY |
82,149,713.00 |
|
TOTAL
LIABILITIES |
135,922,407.00 |
|
SALES |
177,704,904.00 |
|
PROFIT(LOSS) |
1,292,835.00 |
|
LIQUIDITY RATIO |
2.39 |
(Current Assets/Current
Liabilities) |
|
DEBT-TO-EQUITY RATIO |
152.77 |
(Shareholders's
equity/Current Liabilities %) |
|
PROFITABILITY MARGIN |
0.73 |
(Profits/Sales %) |
|
WORKING CAPITAL |
74,507,676.00 |
(Current Assets - Current
Liabilities) |
FINANCIAL SITUATION : Active
Based on the last Financial Statement, this company's Financial
Situation is deemed to be Satisfactory because its liquidity ratio is above average.
Its working capital is positive, which allows the company to pay properly. Its
debt-to-equity ratio is acceptable. Economic results have been satisfactory.
At a commercial level, the only supplier that gave information referred
in good terms to subject's operations. It was not found any adverse against
subject.
PROPERTY OF THE COMPANY .-
Subject's assets include:
- Transportation equipment
- Lab equipment
- Computer equipment
- Office furniture and equipment
- Warehouse equipment.
Coverage: Vehicles and merchandise.
|
Company |
Againts |
Amount |
Expiration |
|
SEGUROS INBURSA |
N/A |
Not specified |
Not specified |
TRADE REFERENCES .-
|
Supplier |
Country |
Tel. |
Line of Credit |
Monthly Average |
Terms(days) |
Perfomance? |
Time |
Products/Services |
|
Fersinsa GB S.A. de C.V. |
MEXICO |
(52844) 4580000 |
|
Not specified |
60 days |
Prompt |
1999 |
Pharmaceutical products |
|
Astroqim S.A. de C.V. |
MEXICO |
(5255) 57798350 |
Open |
|
60 days |
Prompt |
Sv.years |
Raw material |
|
Egon Meyer S.A. de C.V. |
MEXICO |
(5255) 53105706 |
Open |
|
60 days |
Prompt |
Sv.years |
Chemicals |
NOTE: Other Suppliers did not provide information or could not be
consulted.
|
Supplier |
Country |
Tel. |
|
Biesterfield |
GERMANY |
N/A |
|
Hetera Drugs Ltd. |
INDIA |
N/A |
|
Granules |
INDIA |
N/A |
|
Pioneer Pharmaut SL |
SPAIN |
N/A |
|
MPI Pharmaceutical GMBH |
GERMANY |
N/A |
|
Jebsen & Jebsen Gmbh |
GERMANY |
N/A |
|
Sinbiotik Internacional S.A.
de C.V. |
MEXICO |
(5255) 53987939 |
CREDIT HISTORY .-
It was not found any problems with subject's payments.
BANKERS .-
|
Bank |
Contact |
Telephone |
Account # |
DC (S/.) |
FC (US$) |
|
BANCO NACIONAL DE MEXICO
S.A. |
N/A |
N/A |
N/A |
N/A |
N/A |
|
BBVA BANCOMER S.A. |
N/A |
N/A |
N/A |
N/A |
N/A |
|
COMMERCE BANK |
N/A |
N/A |
N/A |
N/A |
N/A |
It was only possible to learn about that subject carries out its
financial operations through the above-mentioned banks.
It should be mentioned that in
REPUTATION .-
NOTHING AGAINST COMPANY
Consulted Credit Amount : CREDIT
LIMIT
Subject is eligible to be granted a credit limit of US$100,000.=
NOTE: The Opinion given is confidential referential and with out
liability
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.20 |
|
|
1 |
Rs.73.16 |
|
Euro |
1 |
Rs.61.88 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Company |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.